{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/whooping-cough/prescribing-information/co-trimoxazole/","result":{"pageContext":{"chapter":{"id":"83991d80-1c24-5213-80d8-d98f94f7165f","slug":"co-trimoxazole","fullItemName":"Co-trimoxazole","depth":2,"htmlHeader":"<!-- begin field 38549c3c-ef8a-46c7-b634-72dbc4f90143 --><h2>Co-trimoxazole</h2><!-- end field 38549c3c-ef8a-46c7-b634-72dbc4f90143 -->","summary":"","htmlStringContent":"<!-- begin item f01e62cd-b570-4c33-a577-ab567f3589a0 --><!-- end item f01e62cd-b570-4c33-a577-ab567f3589a0 -->","topic":{"id":"35659c4f-d80b-5e8b-8b62-22146482d6da","topicId":"aa36f776-3bec-44aa-ba6f-c147b57f7328","topicName":"Whooping cough","slug":"whooping-cough","lastRevised":"Last revised in January 2021","chapters":[{"id":"57f71ac2-7f00-5c54-b9dc-d2d7d9425e4f","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"43ee7c18-a7d1-5aaf-b7b1-e9f8aec21522","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"c127e190-a190-5b44-9ef6-9f30b6527b35","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"86a8dc5e-4401-57e4-a893-30e9405e7e8d","slug":"changes","fullItemName":"Changes"},{"id":"f0e375ca-3710-5454-996c-600b6987bc09","slug":"update","fullItemName":"Update"}]},{"id":"9165fc1a-9d30-5e58-9bb2-a1b68eab43c6","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"39a4fa70-e2db-566b-9c9e-0be39b8be0ac","slug":"goals","fullItemName":"Goals"},{"id":"7fd8bab1-ed01-583f-925f-50b956b1065b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4c330a84-fe34-5261-acf3-bcd6c9b9d2ef","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"dab08320-4d0b-59e9-b25a-28f9cc15908b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a088fcbf-b960-56c1-a102-2cb980dc3cb0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"05a22688-4243-5ec9-814d-874c82306da6","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"32d067f6-839d-500a-9f89-494e3487c3fd","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"76a32750-044c-5bf9-b055-60be74d61d05","slug":"definition","fullItemName":"Definition"},{"id":"ba541f69-d5c7-5bfb-bcef-ec03ceaceee7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"5d07a89e-bdd9-5e79-81eb-87c32d271af2","slug":"prognosis","fullItemName":"Prognosis"},{"id":"054c3198-af7f-5c25-8611-2cc61ad8a848","slug":"complications","fullItemName":"Complications"}]},{"id":"41fa1350-a42e-56da-b04d-aba216545b35","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6eb9d7f5-32ca-5aaa-b5f3-1ac34aeff0d6","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"02ae0369-3f8d-5a31-b677-d0a1d5d0e6f9","slug":"making-a-clinical-diagnosis","fullItemName":"Making a clinical diagnosis"},{"id":"0a55b0ed-e1e6-5bf2-a57c-ec4bda345338","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"95029ae8-217f-53b1-b552-1b19a63a1460","slug":"notification-confirmation","fullItemName":"Notification and confirmation"}]},{"id":"e9f5a777-75d4-5e44-9222-d0679a35b79f","fullItemName":"Management","slug":"management","subChapters":[{"id":"be786901-8aa4-5cf6-977f-07c667507f85","slug":"management-of-whooping-cough","fullItemName":"Scenario: Management of whooping cough"}]},{"id":"73184dce-2f33-555a-99f5-1f7676165d85","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"c6240279-15ed-57da-bbbc-a009ed1fe10d","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"f55a7bd1-232f-5264-b591-1615754d7cd4","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"69df3991-1f78-5988-a277-eba775516ffc","slug":"azithromycin","fullItemName":"Azithromycin"},{"id":"83991d80-1c24-5213-80d8-d98f94f7165f","slug":"co-trimoxazole","fullItemName":"Co-trimoxazole"},{"id":"9e55dced-d32c-53b0-9767-ec433fb86549","slug":"paracetamol","fullItemName":"Paracetamol"},{"id":"6a290b31-ff8d-56f2-aa28-4f7fc47c5ff6","slug":"ibuprofen","fullItemName":"Ibuprofen"}]},{"id":"0cb3e998-9c97-56e6-86e8-373f09a16cee","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"06233f93-f6af-5a86-a0d3-f66b18e22f6f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"933608bb-6634-5ada-9704-c47966180200","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b65931da-6bf7-5353-a3e6-b7b3f0da241d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"9e63923e-f250-5bb8-b436-8c4426b094d4","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"8a644bf0-15a8-56ea-a310-b3625c09b8ce","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4da49df8-81c2-588b-aaf2-014b7ddf9181","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"20d6c374-e4e4-55e9-8247-f63253537476","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"73184dce-2f33-555a-99f5-1f7676165d85","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"f241a7c4-4e5d-50e9-b2a4-090ea6131e31","slug":"dose","fullItemName":"Dose","depth":3,"htmlHeader":"<!-- begin field d40dcd12-ca0c-416a-8c33-9ac1cd5770ea --><h3>Dosing information</h3><!-- end field d40dcd12-ca0c-416a-8c33-9ac1cd5770ea -->","summary":"","htmlStringContent":"<!-- begin item 5109ab34-4db2-4722-a9b1-90d90cd78361 --><!-- begin field 87dd1bfd-5e0f-46cf-af5e-0550110d4915 --><ul><li>Co-trimoxazole is not licensed for use in infants below 6 weeks of age.</li><li>Prescribe co-trimoxazole for 7 days:<ul><li>Infants 6 weeks to 5 months: 120 mg twice a day.</li><li>Infants and children 6 months to 5 years: 240 mg twice a day.</li><li>Children 6-11 years: 480 mg twice a day.</li><li>Children 12 years and over and adults: 960 mg twice a day.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">PHE, 2016b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">BNF 72, 2016</a>]</p><!-- end field 87dd1bfd-5e0f-46cf-af5e-0550110d4915 --><!-- end item 5109ab34-4db2-4722-a9b1-90d90cd78361 -->","subChapters":[]},{"id":"cfecb804-77f2-58c7-b89a-0c5869ed517c","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field fc346ce9-703a-4c0b-8bd7-1ef27313f0cd --><h3>Contraindications and cautions</h3><!-- end field fc346ce9-703a-4c0b-8bd7-1ef27313f0cd -->","summary":"","htmlStringContent":"<!-- begin item 95779972-dde6-43e2-8415-8a178a7c5cb1 --><!-- begin field 418d075d-ad76-4ea4-8b80-f015f599cdf6 --><p><strong>Do not prescribe co-trimoxazole to people with:</strong></p><ul><li>Severe hepatic failure, marked liver parenchymal damage, or jaundice.</li><li>Severe renal insufficiency (unless plasma levels of co-trimoxazole can be monitored regularly).</li><li>Severe haematological disorders such as blood dyscrasias.</li><li>Porphyria.</li></ul><p><strong>Prescribe co-trimoxazole with caution </strong><strong>to people with:</strong></p><ul><li>Marked renal impairment.</li><li>A predisposition to folate deficiency (for example elderly people).</li><li>Severe allergy and asthma.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">ABPI, 2016d</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">BNF 72, 2016</a>]</p><!-- end field 418d075d-ad76-4ea4-8b80-f015f599cdf6 --><!-- end item 95779972-dde6-43e2-8415-8a178a7c5cb1 -->","subChapters":[]},{"id":"edb27a0f-0d76-5a3a-a3da-ae1ac23d3b49","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field e05bbf88-0f59-4287-9818-3b0fd88b640d --><h3>Adverse effects</h3><!-- end field e05bbf88-0f59-4287-9818-3b0fd88b640d -->","summary":"","htmlStringContent":"<!-- begin item 01d7d474-84bc-4605-8234-0e550c04d0de --><!-- begin field 8a9eaa92-a011-42f9-a9fd-bb240dc5d592 --><ul><li><strong>Nausea, vomiting, diarrhoea, headache, hyperkalaemia, vertigo, tinnitus, arthralgia, and myalgia </strong>have been associated with the use of co-trimoxazole.</li><li><strong>Rash </strong>is also a relatively common adverse effect, but very rarely co-trimoxazole may cause Stevens-Johnson syndrome and toxic epidermal necrolysis.</li><li><strong>Other adverse effects include </strong>aplastic anaemia and haemolytic anaemia (older people, people with hepatic or renal failure, and people with poor folate status are more susceptible). Co-trimoxazole may induce haemolysis in some people with glucose-6-phosphate dehydrogenase deficiency.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">ABPI, 2016d</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">BNF 72, 2016</a>]</p><p> </p><!-- end field 8a9eaa92-a011-42f9-a9fd-bb240dc5d592 --><!-- end item 01d7d474-84bc-4605-8234-0e550c04d0de -->","subChapters":[]},{"id":"8d4bdb3f-1a00-5ec8-b1f6-ac5b90a6d12a","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 6fe9d5fd-2ec0-4806-a4dc-f3b91c1a59a9 --><h3>Drug interactions</h3><!-- end field 6fe9d5fd-2ec0-4806-a4dc-f3b91c1a59a9 -->","summary":"","htmlStringContent":"<!-- begin item 1a8d8b06-38b4-45c2-8f89-dee137d904c4 --><!-- begin field 16417580-6e63-4f1a-8f37-4b12120d1578 --><p><strong>Interactions with co-trimoxazole include:</strong></p><ul><li><strong>Angiotensin-converting enzyme (ACE) inhibitors </strong>— risk of severe hyperkalaemia.</li><li><strong>Antiarrhythmics </strong>— increased risk of ventricular arrhythmias with amiodarone.</li><li><strong>Anticoagulants </strong>— effect of warfarin enhanced.<ul><li>Monitor the international normalized ratio (INR), and adjust the warfarin dose accordingly.</li></ul></li><li><strong>Antidiabetics </strong>— effect of sulphonylureas enhanced.</li><li><strong>Antifolates </strong>— if considered appropriate, a folate supplement should be considered for people taking antifolate drugs such as methotrexate or proguanil.</li><li><strong>Antivirals </strong>— plasma concentrations of lamivudine increased, avoid concomitant high-dose co-trimoxazole. Concomitant treatment with zidovudine may increase the risk of haematological adverse effects. Zalcitabine plasma concentrations possibly increased by co-trimoxazole.</li><li><strong>Clozapine </strong>— avoid concomitant use; increased risk of fatal agranulocytosis.</li><li><strong>Ciclosporin </strong>— reversible deterioration in renal function has been reported in people following renal transplantation.</li><li><strong>Digoxin </strong>— may increase digoxin levels, particularly in older people.<ul><li>If there are symptoms of digoxin toxicity (for example, nausea, anorexia, or disturbance of colour vision), check serum digoxin levels.</li></ul></li><li><strong>Diuretics </strong>— for older people concurrently receiving diuretics (mainly thiazides) there is an increased risk of thrombocytopenia.</li><li><strong>Phenytoin </strong>— co-trimoxazole prolongs the half-life of phenytoin and co-administration could result in increased serum phenytoin levels.<ul><li>If symptoms of phenytoin toxicity are present (confusion, blurred vision, nystagmus, ataxia, or drowsiness), monitor serum phenytoin levels and reduce the dose if necessary.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">ABPI, 2016d</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">BNF 72, 2016</a>]</p><!-- end field 16417580-6e63-4f1a-8f37-4b12120d1578 --><!-- end item 1a8d8b06-38b4-45c2-8f89-dee137d904c4 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}